T. Rowe Price Investment Management’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,938,100
Closed -$3.53M 942
2025
Q3
$3.53M Sell
1,938,100
-164,929
-8% -$267K ﹤0.01% 586
2025
Q2
$1.54M Hold
2,103,029
﹤0.01% 613
2025
Q1
$2.1M Sell
2,103,029
-2,899,770
-58% -$4.97M ﹤0.01% 602
2024
Q4
$53M Sell
5,002,799
-225,534
-4% -$2.7M 0.03% 402
2024
Q3
$69.1M Buy
5,228,333
+127,237
+2% +$1.48M 0.04% 356
2024
Q2
$50.1M Buy
5,101,096
+1,517,092
+42% +$15.7M 0.03% 387
2024
Q1
$49.3M Buy
+3,584,004
New +$57.9M 0.03% 398

Other funds holding NMRA